LEXARIA BIOSCIENCE CORP. Cost of Revenue
LEXARIA BIOSCIENCE CORP. (LEXX) reported Cost of Revenue of $0 for the 3-month period ending 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-07-13
- LEXARIA BIOSCIENCE CORP. cost of goods and services sold for the quarter ending 2026-05-31 was $0.00.
- LEXARIA BIOSCIENCE CORP. cost of goods and services sold for the quarter ending 2026-02-28 was $0.00.
- LEXARIA BIOSCIENCE CORP. cost of goods and services sold for the quarter ending 2025-11-30 was $0.00, a 100.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. cost of goods and services sold for the quarter ending 2025-08-31 was $0.00.
- LEXARIA BIOSCIENCE CORP. cost of goods and services sold for fiscal 2025 was $2.72K, a 43.59% decline from fiscal 2024.
- LEXARIA BIOSCIENCE CORP. cost of goods and services sold for fiscal 2024 was $4.82K, a 84.69% decline from fiscal 2023.
- LEXARIA BIOSCIENCE CORP. cost of goods and services sold for fiscal 2023 was $31.50K, a 56.15% decline from fiscal 2022.
- LEXARIA BIOSCIENCE CORP. cost of goods and services sold for fiscal 2022 was $71.84K, a 59.03% decline from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-05-31 | $0.00 10-Q · filed 2026-07-13 | $0.00 derived: sum of 2 quarters · filed 2026-07-13 | $0.00 10-Q · filed 2026-07-13 | $0.00 derived: sum of 4 quarters · filed 2026-07-13 |
| 2026-02-28 | $0.00 10-Q · filed 2026-04-13 | $0.00 10-Q · filed 2026-04-13 | $0.00 derived: sum of 3 quarters · filed 2026-04-13 | $0.00 derived: sum of 4 quarters · filed 2026-07-13 |
| 2025-11-30 | $0.00 10-Q · filed 2026-01-13 | $0.00 derived: sum of 2 quarters · filed 2026-01-13 | $0.00 derived: sum of 3 quarters · filed 2026-07-13 | $0.00 derived: sum of 4 quarters · filed 2026-07-13 |
| 2025-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-28 | $0.00 derived: sum of 2 quarters · filed 2026-07-13 | $0.00 derived: sum of 3 quarters · filed 2026-07-13 | $2.72K 10-K · filed 2025-11-28 |
| 2025-05-31 | $0.00 10-Q · filed 2026-07-13 | $0.00 derived: sum of 2 quarters · filed 2026-07-13 | $2.72K 10-Q · filed 2026-07-13 | $2.72K derived: sum of 4 quarters · filed 2026-07-13 |
| 2025-02-28 | $0.00 10-Q · filed 2026-04-13 | $2.72K 10-Q · filed 2026-04-13 | $2.72K derived: sum of 3 quarters · filed 2026-04-13 | $2.72K derived: sum of 4 quarters · filed 2026-04-13 |
| 2024-11-30 | $2.72K 10-Q · filed 2026-01-13 | $2.72K derived: sum of 2 quarters · filed 2026-01-13 | $2.72K derived: sum of 3 quarters · filed 2026-01-13 | $2.72K derived: sum of 4 quarters · filed 2026-01-13 |
| 2024-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-28 | $0.00 derived: sum of 2 quarters · filed 2025-11-28 | $0.00 derived: sum of 3 quarters · filed 2025-11-28 | $4.82K 10-K · filed 2025-11-28 |
| 2024-05-31 | $0.00 10-Q · filed 2025-07-14 | $0.00 derived: sum of 2 quarters · filed 2025-07-14 | $4.82K 10-Q · filed 2025-07-14 | $4.82K derived: sum of 4 quarters · filed 2025-07-14 |
| 2024-02-29 | $0.00 10-Q · filed 2025-04-14 | $4.82K 10-Q · filed 2025-04-14 | $4.82K derived: sum of 3 quarters · filed 2025-04-14 | $17.57K derived: sum of 4 quarters · filed 2025-04-14 |
| 2023-11-30 | $4.82K 10-Q · filed 2025-01-10 | $4.82K derived: sum of 2 quarters · filed 2025-01-10 | $17.57K derived: sum of 3 quarters · filed 2025-01-10 | $20.53K derived: sum of 4 quarters · filed 2025-01-10 |
| 2023-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26 | $12.75K derived: sum of 2 quarters · filed 2024-11-26 | $15.71K derived: sum of 3 quarters · filed 2024-11-26 | $31.50K 10-K · filed 2024-11-26 |
| 2023-05-31 | $12.75K 10-Q · filed 2024-07-12 | $15.71K derived: sum of 2 quarters · filed 2024-07-12 | $31.50K 10-Q · filed 2024-07-12 | $72.75K derived: sum of 4 quarters · filed 2024-07-12 |
| 2023-02-28 | $2.96K 10-Q · filed 2024-04-09 | $18.75K 10-Q · filed 2024-04-09 | $60.00K derived: sum of 3 quarters · filed 2024-04-09 | $78.64K derived: sum of 4 quarters · filed 2024-04-09 |
| 2022-11-30 | $15.79K 10-Q · filed 2024-01-12 | $57.04K derived: sum of 2 quarters · filed 2024-01-12 | $75.68K derived: sum of 3 quarters · filed 2024-01-12 | $82.07K derived: sum of 4 quarters · filed 2024-01-12 |
| 2022-08-31 | $41.25K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-20 | $59.88K derived: sum of 2 quarters · filed 2023-11-20 | $66.27K derived: sum of 3 quarters · filed 2023-11-20 | $71.84K 10-K · filed 2023-11-20 |
| 2022-05-31 | $18.64K 10-Q · filed 2023-07-14 | $25.02K derived: sum of 2 quarters · filed 2023-07-14 | $30.59K 10-Q · filed 2023-07-14 | $50.90K derived: sum of 4 quarters · filed 2023-07-14 |
| 2022-02-28 | $6.39K 10-Q · filed 2023-04-14 | $11.96K 10-Q · filed 2023-04-14 | $32.27K derived: sum of 3 quarters · filed 2023-04-14 | $92.25K derived: sum of 4 quarters · filed 2023-04-14 |
| 2021-11-30 | $5.57K 10-Q/A · filed 2023-01-18 | $25.88K derived: sum of 2 quarters · filed 2023-01-18 | $85.87K derived: sum of 3 quarters · filed 2023-01-18 | $116.44K derived: sum of 4 quarters · filed 2023-01-18 |
| 2021-08-31 | $20.31K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | $80.30K derived: sum of 2 quarters · filed 2022-11-28 | $110.87K derived: sum of 3 quarters · filed 2022-11-28 | $175.35K 10-K · filed 2022-11-28 |
| 2021-05-31 | $59.99K 10-Q · filed 2022-07-14 | $90.56K derived: sum of 2 quarters · filed 2022-07-14 | $155.04K 10-Q · filed 2022-07-14 | $168.14K derived: sum of 4 quarters · filed 2022-07-14 |
| 2021-02-28 | $30.57K 10-Q · filed 2022-04-11 | $95.05K 10-Q · filed 2022-04-11 | $108.15K derived: sum of 3 quarters · filed 2022-04-11 | $128.47K derived: sum of 4 quarters · filed 2022-04-11 |
| 2020-11-30 | $64.48K 10-Q · filed 2022-01-14 | $77.58K derived: sum of 2 quarters · filed 2022-01-14 | $97.90K derived: sum of 3 quarters · filed 2022-01-14 | $156.00K derived: sum of 4 quarters · filed 2022-01-14 |
| 2020-08-31 | $13.10K derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-29 | $33.42K derived: sum of 2 quarters · filed 2021-11-29 | $91.53K derived: sum of 3 quarters · filed 2021-11-29 | $99.38K 10-K · filed 2021-11-29 |
| 2020-05-31 | $20.32K 10-Q · filed 2021-07-15 | $78.42K derived: sum of 2 quarters · filed 2021-07-15 | $86.28K 10-Q · filed 2021-07-15 | $101.23K derived: sum of 4 quarters · filed 2021-07-15 |
| 2020-02-29 | $58.11K 10-Q · filed 2021-04-14 | $65.96K 10-Q · filed 2021-04-14 | $80.91K derived: sum of 3 quarters · filed 2021-04-14 | $84.00K derived: sum of 4 quarters · filed 2021-04-14 |
| 2019-11-30 | $7.85K 10-Q · filed 2021-01-14 | $22.80K derived: sum of 2 quarters · filed 2021-01-14 | $25.90K derived: sum of 3 quarters · filed 2021-01-14 | $28.59K derived: sum of 4 quarters · filed 2021-01-14 |
| 2019-08-31 | $14.95K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-15 | $18.05K derived: sum of 2 quarters · filed 2020-10-15 | $20.73K derived: sum of 3 quarters · filed 2020-10-15 | $22.89K 10-K · filed 2020-10-15 |
| 2019-05-31 | $3.10K 10-Q · filed 2020-06-29 | $5.79K derived: sum of 2 quarters · filed 2020-06-29 | $7.94K 10-Q · filed 2020-06-29 | $10.89K derived: sum of 4 quarters · filed 2020-06-29 |
| 2019-02-28 | $2.69K 10-Q · filed 2020-04-03 | $4.85K 10-Q · filed 2020-04-03 | $7.79K derived: sum of 3 quarters · filed 2020-04-03 | $10.22K derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-11-30 | $2.16K 10-Q · filed 2020-01-09 | $5.10K derived: sum of 2 quarters · filed 2020-01-09 | $7.53K derived: sum of 3 quarters · filed 2020-01-09 | $21.24K derived: sum of 4 quarters · filed 2020-01-09 |
| 2018-08-31 | $2.95K derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-14 | $5.37K derived: sum of 2 quarters · filed 2019-11-14 | $19.09K derived: sum of 3 quarters · filed 2019-11-14 | $25.18K 10-K · filed 2019-11-14 |
| 2018-05-31 | $2.43K 10-Q · filed 2019-07-08 | $16.14K derived: sum of 2 quarters · filed 2019-07-08 | $22.24K 10-Q · filed 2019-07-08 | |
| 2018-02-28 | $13.71K 10-Q · filed 2019-04-15 | $19.81K 10-Q · filed 2019-04-15 | ||
| 2017-11-30 | $6.10K 10-Q · filed 2019-01-11 | |||
| 2017-08-31 | $29.75K 10-K · filed 2018-11-14 | |||
| 2016-08-31 | $45.62K 10-K · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |